For Calibrate's medication management, should we emphasize broader GLP-1 options or concentrate on optimizing results with a more limited formulary?

Introduction

The trade-off we're considering for Calibrate's medication management is whether to emphasize broader GLP-1 options or concentrate on optimizing results with a more limited formulary. This decision will significantly impact our product strategy, user experience, and business outcomes. I'll analyze this trade-off by examining key factors, designing experiments, and providing a data-driven recommendation.

Step 1

Clarifying Questions (3 minutes)

• Context: I'm assuming Calibrate is a digital health platform focusing on weight management. Is this correct, and are there any specific market conditions or competitive pressures we should consider?

Why it matters: Helps frame the decision within the broader business context Expected answer: Confirmation of business model and key market dynamics Impact on approach: Would influence how we prioritize user needs vs. business goals

• Business Context: Based on the emphasis on medication management, I'm thinking GLP-1 drugs are a core part of Calibrate's offering. How does our revenue model relate to medication management – do we have partnerships with pharmaceutical companies or insurance providers?

Why it matters: Understanding revenue streams helps prioritize business objectives Expected answer: Details on revenue sources and key partnerships Impact on approach: Would affect how we balance user experience with financial considerations

• User Impact: I'm assuming we have different user segments with varying needs. Can you provide insights into our primary user personas and their typical journey through our medication management process?

Why it matters: Ensures we're addressing the needs of our core user base Expected answer: Description of 2-3 key user personas and their typical behaviors Impact on approach: Would guide our decision on formulary breadth vs. depth

• Technical Feasibility: Considering the potential need to integrate with various medication databases or insurance systems, what are our current technical capabilities and limitations in expanding our GLP-1 options?

Why it matters: Helps assess the feasibility and resource requirements of each option Expected answer: Overview of current integration capabilities and potential challenges Impact on approach: Would influence the timeline and scope of implementing changes

• Timeline and Resources: Given the potential impact on user experience and business outcomes, how urgent is this decision, and what resources do we have available for implementation?

Why it matters: Helps prioritize this decision against other initiatives Expected answer: Indication of timeline pressure and available team capacity Impact on approach: Would affect the scale and speed of our recommended solution